Michigan's triplicate prescription program now in effect
Wagenknecht, L.D.
Michigan Medicine 88(8): 32-33
1989
ISSN/ISBN: 0026-2293 PMID: 2586343 Document Number: 329672
Document emailed within 1 workday
Related Documents
Rodriguez, R.F. 1991: The impact of the New York triplicate prescription program on the Hispanic community New York State Journal of Medicine 91(11 Suppl): 24S-27SGage, T.W. 1982: Drug substitution and triplicate prescription forms Texas Dental Journal 99(1): 16-17
Stabenow, D. 2005: A prescription for addressing Michigan's nursing shortage Michigan Nurse 78(7): 11
Zunzunegui, M.V. 1999: Is the medical prescription of heroin a treatment option for heroin addiction? The PEPSA Team (The Experimental Program of Narcotic Prescription in Andalucía Medicina Clinica 113(6): 219-221
Auer, H.A. 1977: Michigan medical education program figures Michigan Medicine 76(20): 364-365
Powsner, R.M. 1984: Medical arbitration--how the Michigan program measures up Michigan Medicine 83(13): 136 138 140-2
Kapron, K.A.; Nix, W.; Smith-Wheelock, L. 1996: Getting patients back to work: an update on the NKF Michigan Renal Rehabilitation Program Nephrology News and Issues 10(11): 44-8 53
Cretens, M.L. 1977: A hypertension screening program of children in Delta and Menominee countries (Michigan) Journal of the American Medical Women's Association 32(6): 216-217
Brown, E.M. 1971: Michigan State University's Four Year Baccalaureate Degree Program in Medical Technology American Journal of Medical Technology 37(3): 102-105
Coffey, R.J.; Finger, R.E. 1990: Employee involvement program changes and the total quality process: the University of Michigan Medical Center experience Journal of the Society for Health Systems 2(1): 50-60
Garrison, G.; Shen, M.; Naik, P.; Kovach, M. 2011: Recommended reading from the University of Michigan Pulmonary and Critical Care Fellows: Marc Peters-Golden, M.D., program director American journal of respiratory and critical care medicine 183(1): 129-130
Masters, B.L. 1974: Michigan State Medical Society and the Michigan bar Michigan Medicine 73(12): 179
Lennard, E.L.; Feinberg, P.E. 1994: Overview of the New York State program for prescription drug benefits American Journal of Hospital Pharmacy 51(23): 2944-2948
Cutler, M.R. 1980: The public significance of privately-owned forests. Remarks prepared for delivery by the Assistant Secretary for Natural Resources and Environment, to the Michigan State Forestry Planning Commission, Lansing, Michigan, July 28, 1980 Major news releases and speeches United States Department of Agriculture Office of Governmental and Public Affairs: 8 1, 6-9
Aguilar Parada, E.; Rábago Velasco, M.; Moreno Cano, H.; Cortés Gallegos, V. 1992: Premature ovarian insufficiency and nuclear organizer regions in triplicate Ginecologia y Obstetricia de Mexico 60: 336-338
Castro-Ríos, Aélica.; Reyes-Morales, H.; Pérez-Cuevas, R. 2008: An evaluation of a continuing medical education program for primary care services in the prescription of hypoglycemic agents in diabetes mellitus type 2 Salud Publica de Mexico 50 Suppl. 4: S445-S452
Nagata, J.M.; Cohen, C.R.; Young, S.L.; Wamuyu, C.; Armes, M.N.; Otieno, B.O.; Leslie, H.H.; Dandu, M.; Stewart, C.C.; Bukusi, E.A.; Weiser, S.D. 2014: Descriptive characteristics and health outcomes of the food by prescription nutrition supplementation program for adults living with HIV in Nyanza Province, Kenya Plos one 9(3): E91403
Moreau, C.; Hall, K.; Trussell, J.; Barber, J. 2013: Effect of prospectively measured pregnancy intentions on the consistency of contraceptive use among young women in Michigan Human Reproduction 28(3): 642-650
1982: Concerning the case of United States v. American Pharmaceutical Association and Michigan State Pharmaceutical Association, Civil No. G75-558 CA5, W.D. Michigan American Pharmacy 22(8): 49-51
O'Reilly, D.J.; Goeree, R.A.; Tarride, J-Eric.; James, C.; Parfrey, P.S. 2009: The unintended (and costly) effects due to the introduction of an unrestricted reimbursement policy for atypical antipsychotic medications in a Canadian public prescription drug program: 1996/97 to 2005/06 Canadian Journal of Clinical Pharmacology 16(2): E346-E359